A ge is the most important risk factor for the development of cognitive decline and dementia. Nevertheless, memory concerns are also prevalent in younger age groups, prompting referral of such patients from primary care to dedicated memory clinics for assessment. Because of the operation of age criteria in some memory clinics, for example those conducted under the auspices of geriatricians and old age psychiatrists (although following a national directive some old age psychiatry clinics now eschew an age cut-off), many of these younger patients are seen in neurology-led memory clinics to be investigated for possible early-onset dementias, the differential diagnosis of which differs somewhat from that in older patients. 1 A consequence of this case mix may be to influence the results of pragmatic diagnostic test accuracy studies of CSIs performed in this setting, 2 as young patients have a lower prior probability of dementia and mild cognitive impairment (MCI) than older patients. The diagnostic utility of CSIs in older people might therefore be obscured where the case mix is heterogeneous.
The aim of the study presented here is to examine the screening utility of five short CSIs for the diagnosis of dementia and MCI versus subjective memory complaint (SMC) in older people (≥65 years), ie a sample enriched for those at greatest risk of cognitive impairment and dementia. Information was collated from several pragmatic diagnostic test accuracy studies undertaken in a secondary care setting (a dedicated neurology-led cognitive disorders clinic based in a regional neuroscience centre) of CSIs taking approximately 5-10 minutes to administer. This type of analysis has previously been reported for the short Montreal Cognitive Assessment (s-MoCA). 3 
Materials and methods
The datasets from several pragmatic prospective diagnostic test accuracy studies undertaken in the authors' clinic were used, [4] [5] [6] [7] [8] [9] All studies followed a similar protocol.
2 Cross-sectional assessment of consecutive outpatient referrals comprised semi-structured patient history enquiring about cognitive symptoms and functional performance, with collateral history where possible; neuroradiological examination (brain CT in all patients; interval MRI in some cases); and formal neuropsychological assessment in some cases. Administration of CSIs occurred on the same day as, but separate from, the cross-sectional assessment. Standard diagnostic criteria for dementia (DSM-IV) and MCI (Petersen) were used; absence of dementia or MCI was categorised as subjective memory complaint (SMC). Criterion diagnosis (reference standard) was by judgment of an experienced clinician based on diagnostic criteria but blinded to CSI scores in order to avoid review bias. STARDdem guidelines for reporting diagnostic test accuracy studies in dementia were observed. 15 Data analysis was as follows. Effect sizes (Cohen's d) for diagnosis of dementia versus MCI and for MCI versus SMC were calculated for each of the CSIs as the difference of the means of diagnostic groups divided by the weighted pooled s t a n d a r d d e v i a t i o n s o f t h e groups. 16, 17 As per Cohen, effect sizes were classified as small (0.2-0.3), medium (0.5) or large (≥0.8). 16 Using test cut-offs specified in index studies of each CSI in order to avoid introduction of bias, 18 standard summary measures of discrimination were calculated for diagnosis of dementia versus MCI and for MCI versus SMC, namely: correct classification accuracy, sensitivity, specificity, Youden index (Y = sensitivity+speci-ficity-1), positive and negative predictive values (PPV and NPV), predictive summary index (PSI = PPV+NPV-1); positive and negative likelihood ratios, and diagnostic odds ratio. The Youden index is a way of combining sensitivity and specificity in a unitary measure of test accuracy, the maximum value of which may be used to optimise test cut-offs for maximal sensitivity and specificity. 2 As predictive values are influenced by the prevalence of the target disease in the population undergoing testing, comparison of these values between the whole cohort and the older subgroup was of particular interest.
Results
In each pragmatic diagnostic test accuracy study, about one-third of the patients were aged ≥65 years, with the exception of the AD8 study where around 50% were elderly (Table 1 , column 5). AD8 is based on collateral history and hence dependent on the attendance of an informant, which is more likely to happen with older individuals. 19 As anticipated, the prevalence of cognitive impairment (dementia and MCI) was higher in the older age group compared with the whole cohort ( Table 1, compare (Table 2) showed that in all instances these were larger in the older patients than in the whole cohort (Figure 1 ). Of note, medium effect sizes for diagnosis of dementia versus MCI using MMSE and AD8 were increased to large in the older patient group. A medium effect size for the diagnosis of MCI versus SMC was increased to large for 6CIT, but AD8 effect size remained medium for this diagnosis. Largest effect sizes for dementia diagnosis in the older subgroup were found using MoCA and 6CIT. Largest effect sizes for MCI diagnosis in the older subgroup were found using MoCA and MACE, as previously reported for the whole cohort unselected for age. 20 Standard summary measures of discrimination for diagnosis of Tables 3  and 4 respectively. For dementia diagnosis, all tests were very sensitive but not very specific for both the whole cohorts and the older subgroups. Highest sensitivities in the older subgroup were achieved by MACE and MoCA, but the best balance of sensitivity and specificity, calculated as the Youden index, was seen with 6CIT.
Positive predictive values were higher for all tests in the older subgroup compared with the whole cohort, but this was not the case for negative predictive values, which were lower for both 6CIT and AD8.
In the older patients, the best balance of PPV and NPV, calculated as the predictive summary index (PSI), was seen with 6CIT, followed by MACE and MoCA.
For MCI diagnosis, sensitivity was very high for MACE, MoCA, and AD8, and comparable in both the whole cohort and the older subgroup. The highest Youden index in the older patients was achieved by the MMSE, closely followed by MACE.
Positive predictive values for MCI diagnosis were higher for all tests in the older subgroup compared with the whole cohort, but this was not the case for negative predictive values, which were lower for all tests with the exception of AD8. The highest PSI in the older patients was achieved by the MACE, closely followed by AD8.
Discussion
This analysis suggests that all the CSIs examined in these pragmatic diagnostic test accuracy studies are acceptable to, and can be used with confidence in, older patients. Most measures of diagnostic performance, both effect sizes (Cohen's d) and standard paired and unitary measures of discrimination, were improved in the subgroup of older patients as compared with the whole cohort, presumably reflecting the higher prevalence of dementia and MCI in this subgroup. A similar finding was made in a previous report on the effect size of the short MoCA (s-MoCA). 3 The study has a number of shortcomings. Firstly, only a limited number of the many available CSIs 21 have been examined. Omissions include both patient-related performance tests such as the Addenbrooke's Cognitive Examination (ACE) and its iterations (ACE-R and ACE-III) and the Clock Drawing Test, and informant scales such as the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). Secondly, the comparisons made involved historical cohorts rather than head-to-head studies. Thirdly, it should always be remembered that CSIs are not diagnostic tests in themselves.
The choice of which CSI to use in older patients will depend on a number of factors, not least clinician preference, but may be guided by the data presented here.
For dementia diagnosis in older patients, if a highly sensitive test is required, ensuring few false negatives (ie cases mistaken for non-cases) but at the cost of many false positives (ie non-cases mistaken for cases), then any one of the tests examined may suffice. Surprisingly, even MMSE was very sensitive for dementia diagnosis in this study, whereas generally it is acknowledged to be a low-sensitivity high-specificity test. 22 Effect sizes were largest for MoC A and 6CIT.
For MCI diagnosis in older patients, MACE, MoCA and AD8 stand out as the most sensitive tests. Effect sizes were largest for MoCA and MACE.
In conclusion, a number of short CSIs may be helpful in clinical practice as a first step to screen for the diagnosis of dementia or MCI in older patients. Dependent upon the results of these tests, a more detailed assessment, which may include structural brain imaging, formal cognitive assessment, and sophisticated biomarker studies (CSF markers, functional neuroimaging for amyloid), may be indicated to establish or refute the diagnosis of dementia or MCI. 
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